US Stock MarketDetailed Quotes

SRTS Sensus Healthcare

Watchlist
  • 8.890
  • -0.040-0.45%
Close Nov 22 16:00 ET
  • 8.870
  • -0.020-0.22%
Pre 06:16 ET
145.71MMarket Cap15.60P/E (TTM)

Sensus Healthcare Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
126.76%8.84M
104.09%9.24M
212.33%10.66M
-45.20%24.41M
-4.10%12.57M
-56.74%3.9M
-62.52%4.53M
-66.98%3.41M
64.68%44.53M
0.61%13.1M
Operating revenue
126.76%8.84M
104.09%9.24M
212.33%10.66M
-45.20%24.41M
-4.10%12.57M
-56.74%3.9M
-62.52%4.53M
-66.98%3.41M
64.68%44.53M
0.61%13.1M
Cost of revenue
88.53%3.6M
100.00%3.82M
123.27%4M
-30.59%10.35M
-0.38%4.74M
-39.13%1.91M
-50.10%1.91M
-43.81%1.79M
48.24%14.9M
14.03%4.75M
Gross profit
163.45%5.24M
107.06%5.42M
310.73%6.66M
-52.54%14.06M
-6.22%7.83M
-66.14%1.99M
-68.28%2.62M
-77.31%1.62M
74.41%29.63M
-5.71%8.35M
Operating expense
-3.58%3.75M
-8.14%3.44M
-17.23%3.78M
-2.40%14.44M
-46.05%2.25M
4.61%3.88M
1.63%3.75M
41.69%4.56M
14.99%14.8M
18.12%4.18M
Selling and administrative expenses
2.89%2.88M
-11.94%2.58M
-17.73%2.85M
-5.05%10.76M
-47.78%1.58M
-5.59%2.8M
2.27%2.92M
39.02%3.46M
20.20%11.34M
24.23%3.02M
-Selling and marketing expense
1.47%1.31M
-37.55%996K
-39.49%1.27M
-11.39%5.61M
-60.34%625K
-28.61%1.29M
-7.70%1.6M
72.33%2.1M
30.82%6.33M
17.96%1.58M
-General and administrative expense
4.10%1.57M
18.81%1.58M
15.76%1.58M
2.96%5.16M
-34.07%952K
30.26%1.51M
17.51%1.33M
7.15%1.36M
9.01%5.01M
31.87%1.44M
Research and development costs
-20.31%863K
5.35%866K
-15.66%926K
6.30%3.68M
-41.54%677K
45.17%1.08M
-0.60%822K
50.82%1.1M
0.70%3.46M
4.70%1.16M
Operating profit
178.89%1.5M
275.87%1.98M
198.23%2.89M
-102.58%-382K
33.68%5.58M
-187.69%-1.9M
-124.66%-1.13M
-174.78%-2.94M
259.98%14.83M
-21.56%4.17M
Net non-operating interest income expense
0.72%279K
-14.69%209K
-11.93%214K
161.05%992K
-2.98%228K
134.75%277K
920.83%245K
24,200.00%243K
380K
235K
Non-operating interest income
0.72%279K
-14.69%209K
-11.93%214K
161.05%992K
-2.15%228K
132.77%277K
880.00%245K
24,200.00%243K
18,900.00%380K
23,200.00%233K
Other net income (expense)
-99.67%42K
0
42K
1,278,000.00%12.78M
0
Special income (charges)
--0
----
----
-99.67%42K
--0
--42K
----
----
1,278,000.00%12.78M
--0
-Gain on sale of property,plant,equipment
--0
----
----
-99.67%42K
--0
--42K
----
----
1,278,000.00%12.78M
--0
Income before tax
212.56%1.77M
348.41%2.19M
215.02%3.1M
-97.67%652K
31.72%5.81M
-169.15%-1.58M
-119.20%-882K
-116.13%-2.7M
579.53%27.99M
-17.13%4.41M
Income tax
547.20%559K
215.34%579K
203.12%827K
-95.54%167K
1.08%1.6M
-127.78%-125K
-146.92%-502K
-223.77%-802K
3.75M
1.58M
Net income
183.74%1.22M
524.21%1.61M
220.06%2.27M
-98.00%485K
48.82%4.21M
-179.33%-1.45M
-110.78%-380K
-111.79%-1.89M
488.59%24.24M
-46.80%2.83M
Net income continuous Operations
183.74%1.22M
524.21%1.61M
220.06%2.27M
-98.00%485K
48.82%4.21M
-179.33%-1.45M
-110.78%-380K
-111.79%-1.89M
488.59%24.24M
-46.80%2.83M
Minority interest income
Net income attributable to the parent company
183.74%1.22M
524.21%1.61M
220.06%2.27M
-98.00%485K
48.82%4.21M
-179.33%-1.45M
-110.78%-380K
-111.79%-1.89M
488.59%24.24M
-46.80%2.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
183.74%1.22M
524.21%1.61M
220.06%2.27M
-98.00%485K
48.82%4.21M
-179.33%-1.45M
-110.78%-380K
-111.79%-1.89M
488.59%24.24M
-46.80%2.83M
Basic earnings per share
177.78%0.07
600.00%0.1
216.67%0.14
-97.96%0.03
52.94%0.26
-181.82%-0.09
-109.52%-0.02
-112.37%-0.12
488.00%1.47
-46.88%0.17
Diluted earnings per share
177.78%0.07
600.00%0.1
216.67%0.14
-97.95%0.03
52.94%0.26
-181.82%-0.09
-109.52%-0.02
-112.37%-0.12
484.00%1.46
-46.88%0.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 126.76%8.84M104.09%9.24M212.33%10.66M-45.20%24.41M-4.10%12.57M-56.74%3.9M-62.52%4.53M-66.98%3.41M64.68%44.53M0.61%13.1M
Operating revenue 126.76%8.84M104.09%9.24M212.33%10.66M-45.20%24.41M-4.10%12.57M-56.74%3.9M-62.52%4.53M-66.98%3.41M64.68%44.53M0.61%13.1M
Cost of revenue 88.53%3.6M100.00%3.82M123.27%4M-30.59%10.35M-0.38%4.74M-39.13%1.91M-50.10%1.91M-43.81%1.79M48.24%14.9M14.03%4.75M
Gross profit 163.45%5.24M107.06%5.42M310.73%6.66M-52.54%14.06M-6.22%7.83M-66.14%1.99M-68.28%2.62M-77.31%1.62M74.41%29.63M-5.71%8.35M
Operating expense -3.58%3.75M-8.14%3.44M-17.23%3.78M-2.40%14.44M-46.05%2.25M4.61%3.88M1.63%3.75M41.69%4.56M14.99%14.8M18.12%4.18M
Selling and administrative expenses 2.89%2.88M-11.94%2.58M-17.73%2.85M-5.05%10.76M-47.78%1.58M-5.59%2.8M2.27%2.92M39.02%3.46M20.20%11.34M24.23%3.02M
-Selling and marketing expense 1.47%1.31M-37.55%996K-39.49%1.27M-11.39%5.61M-60.34%625K-28.61%1.29M-7.70%1.6M72.33%2.1M30.82%6.33M17.96%1.58M
-General and administrative expense 4.10%1.57M18.81%1.58M15.76%1.58M2.96%5.16M-34.07%952K30.26%1.51M17.51%1.33M7.15%1.36M9.01%5.01M31.87%1.44M
Research and development costs -20.31%863K5.35%866K-15.66%926K6.30%3.68M-41.54%677K45.17%1.08M-0.60%822K50.82%1.1M0.70%3.46M4.70%1.16M
Operating profit 178.89%1.5M275.87%1.98M198.23%2.89M-102.58%-382K33.68%5.58M-187.69%-1.9M-124.66%-1.13M-174.78%-2.94M259.98%14.83M-21.56%4.17M
Net non-operating interest income expense 0.72%279K-14.69%209K-11.93%214K161.05%992K-2.98%228K134.75%277K920.83%245K24,200.00%243K380K235K
Non-operating interest income 0.72%279K-14.69%209K-11.93%214K161.05%992K-2.15%228K132.77%277K880.00%245K24,200.00%243K18,900.00%380K23,200.00%233K
Other net income (expense) -99.67%42K042K1,278,000.00%12.78M0
Special income (charges) --0---------99.67%42K--0--42K--------1,278,000.00%12.78M--0
-Gain on sale of property,plant,equipment --0---------99.67%42K--0--42K--------1,278,000.00%12.78M--0
Income before tax 212.56%1.77M348.41%2.19M215.02%3.1M-97.67%652K31.72%5.81M-169.15%-1.58M-119.20%-882K-116.13%-2.7M579.53%27.99M-17.13%4.41M
Income tax 547.20%559K215.34%579K203.12%827K-95.54%167K1.08%1.6M-127.78%-125K-146.92%-502K-223.77%-802K3.75M1.58M
Net income 183.74%1.22M524.21%1.61M220.06%2.27M-98.00%485K48.82%4.21M-179.33%-1.45M-110.78%-380K-111.79%-1.89M488.59%24.24M-46.80%2.83M
Net income continuous Operations 183.74%1.22M524.21%1.61M220.06%2.27M-98.00%485K48.82%4.21M-179.33%-1.45M-110.78%-380K-111.79%-1.89M488.59%24.24M-46.80%2.83M
Minority interest income
Net income attributable to the parent company 183.74%1.22M524.21%1.61M220.06%2.27M-98.00%485K48.82%4.21M-179.33%-1.45M-110.78%-380K-111.79%-1.89M488.59%24.24M-46.80%2.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 183.74%1.22M524.21%1.61M220.06%2.27M-98.00%485K48.82%4.21M-179.33%-1.45M-110.78%-380K-111.79%-1.89M488.59%24.24M-46.80%2.83M
Basic earnings per share 177.78%0.07600.00%0.1216.67%0.14-97.96%0.0352.94%0.26-181.82%-0.09-109.52%-0.02-112.37%-0.12488.00%1.47-46.88%0.17
Diluted earnings per share 177.78%0.07600.00%0.1216.67%0.14-97.95%0.0352.94%0.26-181.82%-0.09-109.52%-0.02-112.37%-0.12484.00%1.46-46.88%0.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data